Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    VistaGen Therapeutics Inc...

    NASDAQ: VTGN · Real-Time Price · USD
    2.21
    -0.10 (-4.54%)
    At close: Jun 13, 2025, 3:59 PM
    2.30
    4.07%
    After-hours: Jun 13, 2025, 05:09 PM EDT

    VistaGen Therapeutics Statistics

    Share Statistics

    VistaGen Therapeutics has 28.86M shares outstanding. The number of shares has increased by 6.8% in one year.

    Shares Outstanding

    n/a
    		 28.86M

    Shares Change (YoY)

    n/a
    		 6.8%

    Shares Change (QoQ)

    n/a
    		 3.66%

    Owned by Institutions (%)

    n/a
    		 50.54%

    Shares Floating

    n/a
    		 26.11M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,531

    FTD / Avg. Volume

    n/a
    		 1.16%

    Short Selling Information

    The latest short interest is 533.81K, so 1.85% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 533.81K

    Short % of Shares Out

    n/a
    		 1.85%

    Short % of Float

    n/a
    		 2.73%

    Short Ratio (days to cover)

    n/a
    		 2.67

    Valuation Ratios

    The PE ratio is -3.56 and the forward PE ratio is -1.38. VistaGen Therapeutics's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -3.56

    Forward PE

    n/a
    		 -1.38

    PS Ratio

    n/a
    		 98.23

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 0.91

    P/FCF Ratio

    n/a
    		 -4.04

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for VistaGen Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 23.55, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 23.55

    Quick Ratio

    n/a
    		 23.55

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.07

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $22,166.67

    Profits Per Employee

    n/a
    		 $-611,708.33

    Employee Count

    n/a
    		 48

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 4K

    Effective Tax Rate

    n/a
    		 -0.01%

    Stock Price Statistics

    The stock price has increased by -37.22% in the last 52 weeks. The beta is 0.69, so VistaGen Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.69

    52-Week Price Change

    n/a
    		 -37.22%

    50-Day Moving Average

    n/a
    		 2.3

    200-Day Moving Average

    n/a
    		 2.73

    Relative Strength Index (RSI)

    n/a
    		 38.81

    Average Volume (20 Days)

    n/a
    		 131,665

    Income Statement

    In the last 12 months, VistaGen Therapeutics had revenue of 1.06M and earned -29.36M in profits. Earnings per share was -1.52.

    Revenue

    n/a
    		 1.06M

    Gross Profit

    n/a
    		 1.06M

    Operating Income

    n/a
    		 -33.02M

    Net Income

    n/a
    		 -29.36M

    EBITDA

    n/a
    		 -32.45M

    EBIT

    n/a
    		 -33.02M

    Earnings Per Share (EPS)

    n/a
    		 -1.52
    Full Income Statement

    Balance Sheet

    The company has 119.17M in cash and 2.12M in debt, giving a net cash position of 117.05M.

    Cash & Cash Equivalents

    n/a
    		 119.17M

    Total Debt

    n/a
    		 2.12M

    Net Cash

    n/a
    		 117.05M

    Retained Earnings

    n/a
    		 -356.21M

    Total Assets

    n/a
    		 92.31M

    Working Capital

    n/a
    		 80.32M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -25.81M and capital expenditures -61K, giving a free cash flow of -25.87M.

    Operating Cash Flow

    n/a
    		 -25.81M

    Capital Expenditures

    n/a
    		 -61K

    Free Cash Flow

    n/a
    		 -25.87M

    FCF Per Share

    n/a
    		 -1.34
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -3103.48% and -2759.59%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -3103.48%

    Pretax Margin

    n/a
    		 -2759.21%

    Profit Margin

    n/a
    		 -2759.59%

    EBITDA Margin

    n/a
    		 -3050.09%

    EBIT Margin

    n/a
    		 -3103.48%

    FCF Margin

    n/a
    		 -2431.77%

    Dividends & Yields

    VTGN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for VTGN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 7, 2023. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Jun 7, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -2.86

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist